Ilias Houda
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.
Journal: Journal for immunotherapy of cancer
Published: June 03, 2026
Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 14, 2026
In the Chemoimmunotherapy Era, There Is Still a Role for Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 31, 2026
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC.
Journal: Journal for immunotherapy of cancer
Published: November 03, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 05, 2025
Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS).
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 27, 2025
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration.
Journal: The Lancet. Respiratory medicine
Published: May 02, 2025
The role of perioperative chemoimmunotherapy in resectable non-small cell lung cancer: insights from the NADIM trial.
Journal: Translational lung cancer research
Published: March 27, 2025
Response to "Letter to Editor-in-Chief" and "Redefining Resectability: Bridging Perspectives in Stage III NSCLC Management".
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 18, 2025
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer.
Journal: JAMA oncology
Published: December 26, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.
Journal: Journal for immunotherapy of cancer
Published: September 08, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 07, 2024
Last Updated: 09/26/2026